DK0941108T3 - Sårheling og behandling af fibrose - Google Patents

Sårheling og behandling af fibrose

Info

Publication number
DK0941108T3
DK0941108T3 DK97947761T DK97947761T DK0941108T3 DK 0941108 T3 DK0941108 T3 DK 0941108T3 DK 97947761 T DK97947761 T DK 97947761T DK 97947761 T DK97947761 T DK 97947761T DK 0941108 T3 DK0941108 T3 DK 0941108T3
Authority
DK
Denmark
Prior art keywords
fibrosis
treatment
wound healing
compound
gelsolin
Prior art date
Application number
DK97947761T
Other languages
Danish (da)
English (en)
Inventor
Mark William James Ferguson
Sharon O'kane
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9625148.3A external-priority patent/GB9625148D0/en
Application filed by Renovo Ltd filed Critical Renovo Ltd
Application granted granted Critical
Publication of DK0941108T3 publication Critical patent/DK0941108T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK97947761T 1996-12-04 1997-12-04 Sårheling og behandling af fibrose DK0941108T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9625148.3A GB9625148D0 (en) 1996-12-04 1996-12-04 Wound healing
US3211596P 1996-12-05 1996-12-05
PCT/GB1997/003243 WO1998024465A1 (en) 1996-12-04 1997-12-04 Wound healing and treatment of fibrosis

Publications (1)

Publication Number Publication Date
DK0941108T3 true DK0941108T3 (da) 2002-11-18

Family

ID=26310539

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97947761T DK0941108T3 (da) 1996-12-04 1997-12-04 Sårheling og behandling af fibrose

Country Status (12)

Country Link
US (2) US20020103112A1 (de)
EP (1) EP0941108B1 (de)
JP (1) JP2001505219A (de)
AT (1) ATE226084T1 (de)
AU (1) AU744750B2 (de)
CA (1) CA2274002A1 (de)
DE (1) DE69716460T2 (de)
DK (1) DK0941108T3 (de)
ES (1) ES2183220T3 (de)
HK (1) HK1025732A1 (de)
PT (1) PT941108E (de)
WO (1) WO1998024465A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000009070A2 (en) * 1998-08-13 2000-02-24 Hadasit Medical Research Services And Development Company Ltd. Inhibition of pathogenic processes related to tissue trauma
CA2388761A1 (en) * 2001-06-18 2002-12-18 Pfizer Inc. Wound healing biomarkers
US7301020B2 (en) * 2003-06-19 2007-11-27 Wisconsin Alumni Research Foundation Macrolide analogs and methods for identifying same
WO2005046454A2 (en) * 2003-11-12 2005-05-26 Trustrees Of The University Of Pennsylvania Methods of using gelsolin to treat or prevent bacterial sepsis
US9408891B2 (en) * 2003-11-12 2016-08-09 The Trustees Of The University Of Pennsylvania Methods of using gelsolin to treat or prevent bacterial sepsis
KR101314461B1 (ko) * 2004-05-12 2013-10-07 더 브리검 앤드 우먼즈 하스피털, 인크. 감염 치료를 위한 겔솔린의 용도
AU2006308431B2 (en) * 2005-10-25 2011-11-10 Adelaide Research & Innovation Pty Ltd Methods and compositions for modulating wound repair
WO2007048202A1 (en) * 2005-10-25 2007-05-03 Women's & Children's Health Research Institute Methods and compositions for modulating wound repair
DK2002258T3 (en) * 2006-03-15 2018-01-02 Brigham & Womens Hospital Inc APPLICATION OF GELSOLINE TO TREAT MULTIPLE SCLEROSIS AND DIAGNOSTICATION OF NEUROLOGICAL DISEASES
PT3279663T (pt) 2006-03-15 2021-09-24 Brigham & Womens Hospital Inc Utilização de gelsolina para o diagnóstico e tratamento de doenças inflamatórias
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
ES2634263T3 (es) * 2008-01-25 2017-09-27 The General Hospital Corporation Usos de diagnóstico terapéuticos de gelsolina en insuficiencia renal
GB201003652D0 (en) * 2010-03-05 2010-04-21 Univ Cardiff Molecular target for healing or treating wounds
CA2818691C (en) * 2010-12-21 2021-08-03 Science Applications International Corporation Methods to identify actin or rdg peptide motifs in wound sites and compositions and methods for wound treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929442A (en) 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
EP0280560B1 (de) 1987-02-27 1994-05-11 EASTMAN KODAK COMPANY (a New Jersey corporation) Mit Nieder-pI-Protein beschichtete Membranstruktur und Verfahren zu ihrer Herstellung und Verwendung
US4950483A (en) * 1988-06-30 1990-08-21 Collagen Corporation Collagen wound healing matrices and process for their production
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
US5464817A (en) * 1990-04-11 1995-11-07 Brigham And Women's Hospital Method for reducing the viscosity of pathological mucoid airway contents in the respiratory tract comprising administering actin-binding compounds with or without DNASE I
ATE171625T1 (de) 1990-04-11 1998-10-15 Brigham & Womens Hospital Therapeutische verwendung von actin-bindenden verbindungen
AU8647991A (en) 1991-08-26 1993-03-16 State of Oregon Acting by and Through The State of Board of Higher Education on Behalf of The Oregon Health Sciences University, The Keratinocyte-derived conditioned medium as a source of growth factors
GB9206861D0 (en) 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines

Also Published As

Publication number Publication date
AU744750B2 (en) 2002-02-28
DE69716460D1 (de) 2002-11-21
CA2274002A1 (en) 1998-06-11
AU5401098A (en) 1998-06-29
US20070087969A1 (en) 2007-04-19
US20020103112A1 (en) 2002-08-01
JP2001505219A (ja) 2001-04-17
PT941108E (pt) 2003-01-31
ATE226084T1 (de) 2002-11-15
US7566446B2 (en) 2009-07-28
EP0941108B1 (de) 2002-10-16
HK1025732A1 (en) 2000-11-24
WO1998024465A1 (en) 1998-06-11
EP0941108A1 (de) 1999-09-15
ES2183220T3 (es) 2003-03-16
DE69716460T2 (de) 2003-06-26

Similar Documents

Publication Publication Date Title
TR199501137A2 (tr) Terapötik olarak aktif bilesenler
DK0941108T3 (da) Sårheling og behandling af fibrose
NO933239D0 (no) Bioeroderbar innretning for administering av aktive ingredienser
ES2162937T3 (es) Preparado combinado para su aplicacion en enfermedades inmunologicas.
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
IL116479A0 (en) Antifungal compositions and bandage for treatment of nails
BR9406178A (pt) Composição de amino-açucar e glicosaminoglicano para o tratamento e restauração de tecido conectivo
ID22878A (id) Komposisi aktif secara terapi
DK0871473T3 (da) Anvendelse af IL-10 til sårheling med reduceret ardannelse
DK0711140T3 (da) Antimykotisk opløsning til negle
BR9906477A (pt) Cicatrizante de feridas enriquecido com plaquetas aperfeiçoado
DE69431965D1 (de) Wirkstoff gegen fettsucht
ES2221950T3 (es) Dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
FI953615A0 (fi) Haavanparannuskoostumus
ES2152315T3 (es) Xamoneline tartrato.
DK1052991T3 (da) Topisk anvendelse af loperamid til behandling af mikrobielle infektioner
NO960308D0 (no) Terapeutisk aktive benzoksaziner og benzotioanoner
NO974651D0 (no) Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose
ES2171080T3 (es) Composicion para la mejora de la fertilidad y su aplicacion.
ITMI921865A1 (it) Glicerofosfoderivati farmacologicamente attivi
BR9304388A (pt) Composição terapêutica de uso nasal
GB9306974D0 (en) Biologically and therapeutically active agents against hiv-1
GB9017812D0 (en) Biologically and therapeutically active agents against hiv-1
ITMI930795A0 (it) Uso della midesteina come cicatrizzante e composizioni farmaceutiche topiche relative
GB9108962D0 (en) Biologically and therapeutically active agents against hiv-1